Lombard Odier Asset Management (Europe) Ltd - SILENCE THERAPEUTICS PLC ownership

SILENCE THERAPEUTICS PLC's ticker is SLN and the CUSIP is 82686Q101. A total of 30 filers reported holding SILENCE THERAPEUTICS PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
Lombard Odier Asset Management (Europe) Ltd ownership history of SILENCE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2023$33,819,216
+80.0%
3,443,912
+0.8%
1.73%
+96.2%
Q2 2023$18,784,480
-8.0%
3,415,360
+3.7%
0.88%
-12.6%
Q1 2023$20,419,111
-58.4%
3,293,405
+2.3%
1.01%
-49.3%
Q4 2022$49,077,550
+51.9%
3,218,200
-0.0%
1.99%
+19.0%
Q3 2022$32,307,000
+8.9%
3,219,400
+106.2%
1.68%
+47.2%
Q1 2022$29,669,0001,561,5511.14%
Other shareholders
SILENCE THERAPEUTICS PLC shareholders Q3 2022
NameSharesValueWeighting ↓
Aquilo Capital Management, LLC 1,312,233$8,135,8453.37%
TCG Crossover Management, LLC 2,104,875$13,050,2252.54%
M28 Capital Management LP 145,900$904,5801.02%
Lombard Odier Asset Management (Europe) Ltd 3,293,405$20,419,1111.01%
Deep Track Capital, LP 1,951,580$12,099,7960.50%
Lombard Odier Asset Management (USA) Corp 3,959,101$20,689,1700.46%
Frazier Life Sciences Management, L.P. 881,173$5,463,2730.40%
BVF INC/IL 1,508,416$9,352,1790.34%
Parkman Healthcare Partners LLC 158,774$984,3990.21%
Artal Group S.A. 505,074$3,1310.19%
View complete list of SILENCE THERAPEUTICS PLC shareholders